These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30856204)

  • 1. Anxiety, depression and quality of life in acute high risk cardiac disease patients eligible for wearable cardioverter defibrillator: Results from the prospective multicenter CRED-registry.
    Weiss M; Michels G; Eberhardt F; Fehske W; Winter S; Baer F; Choi YH; Albus C; Steven D; Baldus S; Pfister R
    PLoS One; 2019; 14(3):e0213261. PubMed ID: 30856204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein HU; McNitt S; Zareba W; Goldenberg I
    Pacing Clin Electrophysiol; 2018 Oct; 41(10):1307-1313. PubMed ID: 29992590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA; Vermilye K; Moss AJ; Goldenberg I; Klein HU; McNitt S; Zareba W; Kutyifa V
    Heart Rhythm; 2018 Sep; 15(9):1379-1386. PubMed ID: 29678779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA; Koneru JN; Sharma PS; Deshpande S; Wan C; Szymkiewicz SJ
    JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
    Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
    J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients.
    Jacq F; Foulldrin G; Savouré A; Anselme F; Baguelin-Pinaud A; Cribier A; Thibaut F
    Gen Hosp Psychiatry; 2009; 31(3):266-73. PubMed ID: 19410106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the wearable cardioverter defibrillator in advanced heart-failure patients (SWIFT).
    Barsheshet A; Kutyifa V; Vamvouris T; Moss AJ; Biton Y; Chen L; Storozynsky E; Wan C; Szymkiewicz SJ; Goldenberg I
    J Cardiovasc Electrophysiol; 2017 Jul; 28(7):778-784. PubMed ID: 28429542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes using a wearable cardioverter-defibrillator: results from a systematic review.
    Aidelsburger P; Seyed-Ghaemi J; Bonderman D
    Int J Technol Assess Health Care; 2023 Jan; 39(1):e1. PubMed ID: 36606325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW; Vamos M; Sirat AS; Hohnloser SH
    Clin Res Cardiol; 2017 Apr; 106(4):300-306. PubMed ID: 27888304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort.
    Zylla MM; Hillmann HAK; Proctor T; Kieser M; Scholz E; Zitron E; Katus HA; Thomas D
    Heart Vessels; 2018 Nov; 33(11):1390-1402. PubMed ID: 29721674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Wearable defibrillator : Current evidence].
    Duncker D; Veltmann C
    Herzschrittmacherther Elektrophysiol; 2018 Dec; 29(4):362-368. PubMed ID: 30357452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wearable cardioverter defibrillators for patients with long QT syndrome.
    Owen HJ; Bos JM; Ackerman MJ
    Int J Cardiol; 2018 Oct; 268():132-136. PubMed ID: 30041777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.
    Ingles J; Sarina T; Kasparian N; Semsarian C
    Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.
    Healy CA; Carrillo RG
    Heart Rhythm; 2015 Jul; 12(7):1565-73. PubMed ID: 25839113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.
    Duncker D; Haghikia A; König T; Hohmann S; Gutleben KJ; Westenfeld R; Oswald H; Klein H; Bauersachs J; Hilfiker-Kleiner D; Veltmann C
    Eur J Heart Fail; 2014 Dec; 16(12):1331-6. PubMed ID: 25371320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.
    Opreanu M; Wan C; Singh V; Salehi N; Ahmad J; Szymkiewicz SJ; Thakur RK
    J Heart Lung Transplant; 2015 Oct; 34(10):1305-9. PubMed ID: 26094085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patients with a wearable cardioverter-defibrillator (WCD) : Prescription, function and rehabilitation support].
    Schlitt A; Guha M; Noutsias M; Klein HH; Klein HU
    Herz; 2019 Aug; 44(5):379-389. PubMed ID: 29234842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of Quality of Life among Patients with Wearable Cardioverter Defibrillator Therapy (LifeVest®): A Preliminary Study.
    Lackermair K; Schuhmann CG; Kubieniec M; Riesinger LM; Klier I; Stocker TJ; Kääb S; Estner HL; Fichtner S
    Biomed Res Int; 2018; 2018():6028494. PubMed ID: 30050939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.